Cohen M, Zimmet P Z
Med J Aust. 1980 Dec 27;2(13):713-6.
The results in 116 diabetics who were performing long-term home blood-glucose monitoring (HBGM) are presented. By means of Dextrostix and portable glucose meters at home and at work, patients recorded blood glucose (BG) profiles during original treatment and subsequent adjustment, and were followed up for four to 18 months. Initially marked fluctuations in BG levels occurred, with 67% of patients demonstrating hypoglycaemia (clinically silent in 53%) followed by rebound hyperglycaemia (the Somogyi effect). Adjustment of the insulin regimen resulted in reduction in standard deviation of BG concentration from a mean of 4.4 mmol/L to 2.7 mmol/L (P less than 0.001), thus avoiding both hypoglycaemia and extreme hyperglycaemia. Daily insulin dose decreased from a mean of 44 (+/- 21 SD) units to 30 (+/- 12 SD) units per day (P less than 0.001), and the insulin regimens used are described. The results of urine tests correlated poorly with those of HBGM in 67% of patients. Patient acceptance of HBGM was excellent, and it has permanently replaced urine testing in 96% of the subjects. Management based on HBGM resulted in improved diabetic control and life-style, and reduced the frequency of hospital admissions. The need for adequate education in technique and supervision is stressed. HBGM is superior to, and more acceptable than, urine testing as a method of monitoring diabetic control.
本文展示了116名进行长期家庭血糖监测(HBGM)的糖尿病患者的结果。患者通过在家和工作场所使用Dextrostix血糖仪和便携式血糖仪,记录了初始治疗及后续调整期间的血糖(BG)情况,并随访了4至18个月。最初,血糖水平出现明显波动,67%的患者出现低血糖(其中53%为无症状性低血糖),随后出现反弹性高血糖(苏木杰效应)。胰岛素治疗方案的调整使血糖浓度标准差从平均4.4 mmol/L降至2.7 mmol/L(P<0.001),从而避免了低血糖和极端高血糖的发生。每日胰岛素剂量从平均44(±21标准差)单位降至30(±12标准差)单位/天(P<0.001),并描述了所使用的胰岛素治疗方案。67%的患者尿液检测结果与HBGM结果相关性较差。患者对HBGM的接受度很高,96%的受试者已永久取代尿液检测。基于HBGM的管理改善了糖尿病控制和生活方式,减少了住院频率。强调了进行技术充分培训和监督的必要性。作为监测糖尿病控制的方法,HBGM优于尿液检测,且更易被接受。